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Abstract 
During the 90s the increase in health spending which compared to the overall growth had taken 
place at a rather rapid pace experienced a worldwide slow-down. In relation to overall economic 
growth and the expansion of other countries’ health care systems, Austria’s system grew below 
average- a fact which holds particularly true for the years between 1990 and 1997. This 
development may largely be due to a constant consolidation of budget and relatively high prices for 
private households which are possibly overestimated, however. This overestimation of prices are 
probably caused by unascertained productivity improvements which may have occurred in the 
acute care sectors. Within our observation period of 16 years, the private households’ expenditure 
reached a peak with spending on physician services experiencing the fastest increase. Although 
overestimated, the high prices in the health sector together with  sharply rising consumption 
expenditure on health care constitute an increased burden on households.  
Zusammenfassung 
Je reicher ein Land ist, um so mehr wird für den Gesundheitssektor ausgegeben. Das relativ 
schnellere Wachstum der Gesundheitsausgaben ist – global betrachtet – in den 90er Jahren 
träger geworden. Im Verhältnis zum Wirschaftswachstum und im Vergleich mit anderen Ländern 
ist das reale Wachstum der Gesundheitsausgaben pro Kopf in Österreich vor allem in der Periode 
1990 bis 1997 unterdurchschnittlich. Budgetkonsolidierung, relativ hohe Preise für die privaten 
Haushalte, die allerdings auch systematisch überschätzt sein dürften, bei gleichzeitig nicht 
erfaßten, aber ziemlich wahrscheinlichen Produktivitätsfortschritten in den Kernbereichen des 
Gesundheitssektors, könnten die Ursachen für diese Entwicklung sein. Die Ausgaben der privaten 
Haushalte verzeichneten innerhalb von 16 Jahren das größte Plus. Am raschesten wuchsen die 
Ausgaben für Ärztliche Dienste. Im Lichte der, wenngleich wahrscheinlich überschätzten, 
Preisentwicklung bedeutet die Kombination aus relativ hohen Preisen und stark wachsenden 
Konsumausgaben für Gesundheit eine verstärkte Belastung für die privaten Haushalte.  
Keywords 
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1 Introduction: The richer a country, the higher its 
expenditure on health care 
In contrast to a linear correlation, the exponential trend depicted in figure 1 not only 
demonstrates that the development of health spending interacts with the development 
of the GDP but also shows that after a certain level of income an increase in earnings is 
accompanied by a disproportionately sharp rise in health care expenditure. 
Relative to the respective GDP-level, health care expenditures in Poland, in Slovenia 
and in Greece are lower compared to the EU-average. In rich countries, for example 
Austria, Belgium, France, Germany, the Netherlands, Switzerland and the USA, the 
amount spent on health care is high relative to GDP.  
In the following sections we will closely examine the relationship between GDP and 
health care spending and in particular estimate the elasticities of health care 
expenditure with respect to income1. For this purpose the relationship between health 
                                                 
1 The concept of elasticities gives us the chance to quantify by how many percent health spending - ceteris paribus - 
rises when the aggregate income increases by one percent. An income elasticity of one indicates that a one-
percent increase in income leads to a one-percent rise in spending (constant elasticity). If the elasticity ranges 
above one, spending is increasing more rapidly than income (which makes health care services appear to be a 
luxury good). From the beginning of the 70s economists have been engaged in an empirical analysis of the 
relationship between health spending and aggregate income. To get a better understanding of their various 
approaches, please see  Gerdtham, U.-G. et al.: An econometric analysis of health care expenditures: A cross 
section study of the OECD-countries, Journal of Health Economics 11 (1992), p. 63-84, North Holland; Mc Gurie, A. 
et al.: Econometric analysis of National Health expenditures: Can positive economics help to answer normative 
questions? Health Economics 2 (1993), p. 113-126; OECD: Factors affecting health spending: a cross country 
econometric analysis, Annex A, New Directions in Health Care Policiy, Health Policy Studies 7, p. 71-88, Paris.  
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care expenditure and aggregate income is depicted by means of a line. The slope of the 
line is estimated in a cross-section approach which captures all the respective 
countries2. Based on percentage changes in aggregate income, percentage changes in 
health spending help to understand how distinct income levels affect the level of health 
care expenditure3.  
2 Cross Country Estimation 
The relation between Health Expenditures (HE per capita) and GDP (per capita) was 
measured by a linear regression model for the log of the values. For justifying the 
linearity of the relationship both variables were transformed with the logarithm function: 
log( ) log( )HE GDPi i i= + ×a b       (1) 
and elasticities have been computed for the years 1991, 1994, 1996 and 1997. In this 
simple model 1 no time trend was considered. 
In a second model a least square dummy variable approach (Fixed Effects)4 was 
employed to capture both time and country inter-correlation. Extending the least square 
dummy variable approach by considering the time specific effects has the general form, 
where country specific dummies are represented byai  and time specific dummies 
byg t : 
y xit i t it it= + + +a g b e        (2) 
Thus, in our case we have the following model with dummy variables for country and 
time: 
log( ) log( ) lgHE const GDP Dummy Dummy Be ium
Denmark Finland France Germany Greece
Ireland Italy Luxembourg Netherlands Portugal
Spain Sweden UK
it it
it
= + × + × + × + ×
+ × + × + × + × + ×
+ × + × + × + × + ×
+ × + × + × +
b g g a
a a a a a
a a a a a
a a a e
1 2 1
2 3 4 5 6
7 8 9 10 11
12 13 14
91 94
 
                                                 
2 With regard to new findings that had been made concerning the functional relationship between health spending 
and GDP (double-logarithmic function), both variables were measured in logarithms in this analysis. (see further 
Gerdtham, U.-G. et al. (1992). Even in multiple regressions, the relationship between GDP and health spending turns 
out to be most pronounced which is why we solely concentrate on this relationship in our analysis.  
3 The following figures also include Luxemburg, Switzerland and the USA. 
4 See Greene , W.H.- Econometric Analysis, Macmillian Publishing Company, New Jersey 1993 p.444-480. 
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The data base for model 2 was the pool of the countries under consideration with the 
variables for health care expenditure and GDP (in logarithms) for the years 1991, 1994 
and 1997. In this variance-analytical approach the datapoint “Austria 1997” was used as 
the reference category. The occuring effects have to be interpreted as deviation from 
“Austria 1997”. The relation between the variables health expenditure and GDP can be 
seen as adjusted for time and country effects. 
3 Decelerated increase in health spending 
The ratio between the annual growth in GDP per capita and the annual increase in 
health spending per capita shows that the goods and services of a health care system 
appear to be “luxury goods”. From the middle of the 90s, however, the increase in 
spending has been slowed down all over the globe but particularly in the EU countries. 
For example, in 1997 the rise in health care expenditure was slightly lower than the 
increase in income in those countries which had already qualified for the monetary 
union.  
After adjusting for differences in purchasing power expressed in US dollars, GDP and 
health spending significantly correlated in 1991, 1994, 1996 and 1997. The slope of the 
lines depicted in figures 2 to 4 shows the elasticity reflecting the relationship between 
the increase in health spending per capita and the rise in income per capita. Table 1 
summarizes the income elasticities of health spending depicted in figures 2 to 5. 
Furthermore, the countries concerned were classified into certain groups which 
revealed that the income elasticity of health spending experienced a worldwide 
decrease by 25% between 1991 and 1997 and amounted to 1.15 in 1997. Relative to 
aggregate income health spending decreased by 16% between 1991 and 1994 and by 
8% between 1994 and 1997. When we compare 1997 to the years 1991 and 1994, we 
come to the conclusion that either proportionally less money was spent on health care 
in 1997 or other factors not included in the relationship between GDP and health 
spending were growing proportionally stronger. Thus, either the formerly „luxurious“ 
medical services became “necessities” or other factors like structural changes and/or 
the introduction of new institutional rules or new “market systems“ were growing 
increasingly dominant. 
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Figure2: Income Elasticity of Health Expenditure 1991
per capita $ purchasing power parity
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Figure 3: Income Elasticity of Health Expenditure 1994
per capita $ purchasing power parity
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Figure 4: Income Elasticity of the Health Expenditure 1996
per capita $ purchasing power parity
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Figure 5: Income Elasticity of the Health Expenditure 1997
per capita $ purchasing power parity
 
 
3.1 Decelerated growth in health care expenditure in EU countries 
According to our calculations, it is above all the EU countries which seem to cause a 
slow-down in the rise of health spending compared to changes in GDP. The cross-
section analysis of the relative rise in health spending shows that the elasticity was 
decreasing by 25% between 1991 and 1997 when it reached 1.05. This development 
may be due to the EU member states‘ strenuous efforts to meet the convergence 
criteria for participation in the monetary union. In this context it has to be pointed out that 
the share of health spending in overall public expenditure accounts for 10 to 20% within 
the EU. The income elasticity of those 11 European countries which already qualified for 
participation amounted to 0.98 1996 and 1997, respectively, and thus just failed to reach 
1 – a fact which occurs to be a further sign for a decelerated growth in expenditure. 
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Table 1 Income elasticity of health spending 
Model 1 Cross-section measurement 
dependent variable: health spending per capita $ PPP 
  1991 1994 1996 1997 
All the 
countries-21 
log GDP 
(t-value) 
1.55 
(10.59) 
1.30 
(12.36) 
1.25 
(10.54) 
1.15 
(11.16) 
(R2=0.80-0.88) constant 
term  
(t-value) 
-3.45 
(-5.67) 
-2.38 
(-5.38) 
-2.16 
(-4.32) 
-1.71 
(-3.91) 
EU-15 
log GDP 
(t-value) 
1.40 
(6.52) 
1.14 
(6.29) 
1.11 
(4.96) 
1.05 
(6.65) 
(R2=0.63-0.77) constant 
term 
(t-value) 
-2.82 
(-3.12) 
-1.70 
(-2.21) 
-1.59 
(-1.66) 
-1.32 
(-1.94) 
EU-11 
log GDP 
(t-value) 
-- -- 0.98 
(3.48) 
0.98 
(5.02) 
(R2=0.53) constant 
term 
(t-value) 
-- -- -1.02 
(-0.85) 
-1.01 
(-1.20) 
Model 2 Fixed effects measurements  
dependent variable: health spending per capita $ PPP 
  1991, 1994, 1997 
  Coefficient Confidence Interval 
EU-15 log GDP 
(t-value) 
1.45 
(3.89) 
0.69-2.22 
(R2=0,978), 
(F=45.17) 
DW: 2.06 
constant 
term  
(t-value) 
-3.09 
(-1.89) 
 
EU-15, 
Switzerland, 
USA 
log GDP 
(t-value) 
1.29 
(3,87) 
0.61-1.96 
(R2=0,966), 
(F=72.12) 
DW: 2.06 
constant 
term  
(t-value) 
-2.35 
(-1.63) 
 
GDP: gross domestic product per capita $PPP  
t-value: Test statistics for the coefficients. A value ³ 2 confirms the hypothesis that GDP per capita is significantly different from 0 (error 
probability of 5%).  
R2 : coefficient of determination regarding the strength of the relationship between GDP and health spending 
Durbin Watson Test: A test for serially correlated (or autocorrelated) residuals. Values less than 2 indicate positive autocorrelation, a 
common problem in time-series data. Values greater than 2 indicate negative autocorrelation.  
Sources : see tables A1 and A2, calculations by IHS HealthEcon. 
3.2 Individual countries influence worldwide growth in expenditure 
However, a cross section analysis has a disadvantage because it assumes that all 
countries under investigations have a similar propensity to consume health care. In 
addition such an analysis cannot embrace real changes that took place within the 
period studied and/or structural breaks. When looking at the fixed effects measurement 
we see that the relative change in health spending amounted to 1.45 over time. 
However, the corresponding 95% confidence interval is quite wide and ranges from 0.7 
to 2.22. Defining a 5% error probability we found that - adjusted for time trends - France, 
Germany and the Netherlands exhibit a significantly higher elasticity of health spending 
I H S — Maria M. Hofmarcher / Cross-Section Analysis of Health Spending — 7 
 
than Austria. In those countries expenditure on health care either grew excessively or 
proportionally weaker in relation to the rise in GDP. If we include Switzerland and the 
USA into our analysis, the change accounts for 1.29, with France, Germany, the 
Netherlands and the United States having a significant effect on the global elasticity. Our 
results are generally in keeping with those obtained in other studies (see footnote 2). 
The measurement of a fixed effects model for the 21-country sample, however, lessens 
the stability of our parameters which may be due to different determinants not included 
into the relationship between growth in health spending and GDP in the various 
countries. This may have occurred primarily due to the variance of the relation in 
spending and income in the applicant countries (MOEL-4). Nevertheless, the elasticity 
is very likely to dependent on other factors which exert a certain kind of influence on 
health care expenditure5.  
With a low 0.78, the relative change in health spending was out of proportion in the 
Czech Republic, Hungary, Poland and Slovenia (MOEL-4) in 1996. This result 
corresponds to findings obtained in other studies, in which GDP did not correlate sig-
nificantly with health spending and in which no reasonable results could be obtained for 
1997. According to calculations by the World Bank, the elasticity of health spending lies 
between 0.8 and 1.08 in low-income countries (less than US$ 785 per capita) and 
amounts to 1.10 in “middle income countries“ (between US$ 786 and US$ 9,635 per 
capita).6 Apart from the fact that an updating of components included in the national 
accounts distorted the national statistics of transition countries, there might be striking 
disproportionalities between the development of the health care systems and the pace 
of overall economic growth which are inefficient on a macroeconomic basis. This trend 
is further reinforced by the fact that potential life years lost (before age 65) in Central 
and Eastern Europe are approximately 60% higher than the EU average.7 
4 The role of the prices in a health care system 
While the relative increase in health spending took place at a steady pace during the 
1980s, it experienced a slow-down in the first half of the 90s. In addition to that the gap 
between the annual increase in GDP and the annual rise in health care expenditure 
widened. The problems with the measurement of price indices surely account for part 
of the increasing gap but inefficiencies, as well as excessive charges may also be held 
responsible for the change. 
                                                 
5 Blomqvist et al. suggested that all the calculations of elasticity overestimated its real level which was particularly 
due to country-specific factors that had not been taken into account but had nevertheless correlated with income. 
Their criticism, however, refers far more to the methods applied than to the contents. Blomqvist, A.G., Carter, 
R.A.L.: Is Health Care really a luxury? Journal of Health Economics 16 (1997), p. 207-229. 
6 The World Bank: World Development Indicators 1998, Washington D.C., p. 91. 
7 Hofmarcher, M. M: Is Public Health Between East and West? Analysis of Wealth, Health and Mortality in Austria, 
Central and Eastern European Countries, and Croatia Relative to the European Union, Croatian Medical Journal  
39/3 (1998), p. 241-248. 
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4.1 Real per capita spending is up in nearly all the countries 
It is rather striking that relative prices, as well as real spending per capita were growing 
strongly although differences in the set-up and financing of the various health care 
systems were persistent. Between 1981 and 1996 real spending per capita (at constant 
1990 prices), experienced an average annual rise of 1.25% in Germany, 1.93% in the 
USA, 2.12% in Switzerland and 3.59% in France. In Austria the expenditure rose by 1% 
within the same period of time whereas real GDP increased by 1.73% a year. 
Throughout the 80s nominal, as well as real growth rates developed concurrently 
without major gaps between levels. 
4.2 The real increases change as the gap between growth rates widens 
In Austria, France, Germany, the Netherlands, Switzerland, Great Britain and the United 
States, the real rise in GDP per capita amounted to an average of 1.40% between 1981 
and 1996 while the increase in real health spending per capita accounted for 1.92% 
within the same period of time. Table 2 shows that between 1983 and 1989 real per 
capita growth rates equaled 2.55% and 2.72%. From 1990 to 1996, however, they 
experienced a slow-down to 0.42 and 1.25%. 
Within the periods considered, the increase in real health care spending per capita was 
diminishing by an average of more than 50% while real GDP per capita was suffering an 
even stronger decrease. This development led to a displacement effect, as well as to a 
widening in the gap between the two growth rates. Both real increase in income and 
real rise in spending were below average with the latter being a bit higher in all the 
countries except for the USA, Switzerland, and Austria between 1990 and 1996. Within 
our three periods of observation the Dutch health care system grew slightly less in 
relation to the other countries’ systems. 
Real per capita growth has been quite consistent during the 80s. However, in the first 
half of the 90s the tendency became heterogeneous while nominal spending per capita 
grew much stronger than GDP per capita. The sometimes significant differences 
between the institutional set-ups of the various health care systems might have become 
stronger in recent years. Massive structural changes as for example the introduction of 
so-called “quasi-markets“ which have by now become a rather common feature in 
Finland, Italy, Spain, Sweden, Great Britain etc. might incite a medium-term price 
increase. 
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Apart from ever increasing transaction costs regarding the drawing-up of price lists for 
medical services, contracts etc., the practical problem consists of the rather costly 
development of “real“ bargaining prices. According to new findings8 Great Britain and 
Sweden are particularly engaged in a reexamination of the concept of market 
liberalization in the field of health care with the emphasis being once again placed on 
the planning competence of the communities.9 
4.3 Relative prices are up 
Figure 6 shows both the rate of price increase and the relative prices10 then current in 
the EU member states, Switzerland and the USA. Except for Denmark, France, 
Germany, Italy and Spain the rise in prices for medical services are sometimes quite 
higher than the general price level in an economy, which holds also true for Austria. At 
constant 1990 prices, relative prices accounted for 2.58 in 1996 (right scale) which 
shows that the price increase in the health care sector was more than twice as high as 
the overall rise in prices. It is, however, difficult to assess whether prices are “too high” 
                                                 
8 Interview with Victor Fuchs, Health Affairs 17/1 (1998), p. 91-96. Fuchs points out that the change in European 
health spending which unfolds much more slowly than in the USA has to be particularly attributed to supply side 
constraints (p. 95).  
9 Saltman, R. B., Figueras, J.: European Health Care Reform: Analysis of Current Strategies, WHO Regional Office for 
Europe, 1997, Kopenhagen. 
10 Relative prices indicate for example in how far a country’s prices for health care services change in relation to 
other prices.  
Table 2 Growth rates of the gross national product per capita (GDP) and health spending per 
capita (HS) 
 1981-1996 1983-1989 1990-1996 
 nominal real nominal real nominal real 
 GDP HS  GDP HS GDP HS GDP HS GDP HS GDP HS 
Austria 5.19 6.14 1.73 1.00 5.46 6.98 2.21 2.20 4.18 5.86 1.05 0.42 
France 5.73 7.21 1.32 3.59 6.89 8.06 2.12 4.38 2.72 4.25 0.54 2.21 
Germany 3.75 4.56 0.93 1.25 4.73 4.36 2.68 2.49 2.02* 4.83* -1.21* 1.44* 
Netherlands 3.56 3.94 1.77 1.71 3.25 3.14 2.40 1.91 3.51 3.97 1.51 1.46 
Switzerland 3.66 5.93 0.38 2.12 5.46 6.82 2.25 3.62 1.15 3.65 -1.25 0.14 
Great Britain 7.11 8.23 2.16 1.84 8.91 8.37 3.47 1.76 4.75 7.24 1.12 2.24 
USA 4.89 7.77 1.51 1.93 6.38 8.76 2.74 2.69 3.59 5.50 1.14 0.86** 
                   
Average growth 4.84 6.25 1.40 1.92 5.87 6.64 2.55 2.72 3.13 5.04 0.42 1.25 
*including Eastern Germany 
**deflator of health spending estimated for 1995 and 1996 
Sources: OECD Health Data 1998, Central Statistical Office, May, June 1998, IHS-HealthEcon – calculations for 1999. 
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when we have no information about possible improvements in productivity.11 The only 
thing we are able to derive from figure 5 is that in 12 out of 17 countries prices in the 
health sectors increased more rapidly than the general price level. There are various 
factors which surely contribute to a distortion or exaggeration of the extent of price 
increase on health care markets, as for example unascertained improvements in 
productivity12, an excessive rise in the amount of goods used and services performed 
and problems to measure output and outcome, as well as their changes in quality over 
time. A special price index for health care systems might be used to ascertain 
improvements in productivity. Measurement problems concerning the indices which are 
persistent in any calculation of inflation rates explain part of the differences between the 
rates of price increase. Nevertheless, inefficiencies and “real” high prices may also be 
responsible for the development of prices in the health care sector.  
Figure 6: Average Growth Rates of Prices per year 1990 - 1997* (1990=100)
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11 If “potential life years lost“ is regarded as a proxy indicator for improvements in productivity, Austria ranks first 
among all the other countries studied. (see also Hofmarcher, M.M.: Das Gesundheitswesen in Österreich, neue 
Trends, neue Fakten, IHS Working Paper Nr. 19 (1997), Vienna. 
12 Weisbrod (1991) and Newhouse (1992) describe the impact of technological changes and research on the 
spending trend in a health care system. Weisbrod, B.A: “The Health Care Quadrilemma: An Essay on Technological 
Change, Insurance, Quality of Care and Cost Containment”, Journal of Economic Literature 29 (1991), p. 523-52; 
Newhouse, J.P.: “Medical Care Costs: How much Welfare Loss?”, Journal of Economic Perspective 6/3 (1992), p. 
3-21. 
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5 Austria 
5.1 Development in health spending and trends concerning the factors 
connected with it 
In Austria, the propensity to consume health services is high. Thus Austrians apparently 
consider health care to be a superior good. In real terms, however, health spending 
experienced a lower increase than GDP per capita . With regard to a rise in services 
performed, a variety of new goods and services available and an ever increasing life 
expectancy, this result clearly contradicts every experience made so far. However, 
significant measuring difficulties and overcharged prices in the private sector which in 
the view of ever rising consumption expenditure put a particular burden on private 
households might explain this development.  
Figure 7: Development of Health Expenditures (in percent of GDP 1981-1997)
6,8 6,7
6,5 6,6
6,7
6,9 7,1
7,1
7,3 7,2 7,2
7,6
8,1 8,1 8,0 8,0
8,3
5,2
5,1 5,0 5,0
5,1
5,3 5,4 5,4 5,4 5,3 5,3
5,6
6,0 6,0 5,9 5,9
6,0
1,6 1,6 1,5 1,6 1,6
1,6 1,7 1,7
1,9 1,9 1,9
2,1 2,1 2,1 2,1
2,2
2,3
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
8,0
9,0
19
81
19
82
19
83
19
84
19
85
19
86
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
Source: Health Expenditure in Austria, Statistische Nachrichten 5 (1998),  Gesundheitsausgaben 1997: vorläufige Werte, IHS-
HealthEcon calculations 1999
In
 P
ro
ze
n
t 
d
es
 B
IP
Total
Public
Private
 
 
In 1997 overall health care expenditure13 amounted to 8.3% of the GDP (Figure 7) and 
was thus 21.4% higher than in 1981. Public health spending increased by 16.4%. The 
private households‘ consumption expenditure, however experienced a rise of 48% 
between 1981 and 1997. Figure 8 shows that the private households‘ spending on 
physician services as share of their overall health spending increased by 25% within the 
period studied. Compared to public expenditure, private health care spending per capita 
rose significantly. Figure 9 documents the development of nominal spending per capita. 
From 1981 to 1997 private health spending more than tripled. At the end of our period of 
observation the increase in private health spending was 27% higher than public health 
care expenditure, which, however, had also more than doubled from 1981 to 1997. With 
                                                 
13 Health care expenditures in Austria: OECD/VGR - concept; 1981 - 1997: Central Statistical Office, December 1998. 
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regard to constant 1990 prices14 real private spending per capita rose by 70% (see 
Figure 10). 
Figure 8: Development of the Expenditures of private households 1981-1997
(in percent of total expenditures of private households)
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As demonstrated in table 3, the average rise of private nominal spending on physician 
services amounted to slightly more than 10% a year and was thus twice as high as the 
increase in both co-payments and expenditure on private health insurance. Within our 
total period of observation, the nominal health spending of private households rose by 
8.03% with the growth rate amounting to 8.4% between 1982 and 1989 and to 7.7% 
from 1990 to 1997.  
Between 1981 and 1997 public spending on health increased by 6.4% with overall public 
expenditures rising by 5.9% and overall health care expenditure increasing by 6.7% per 
year.  
The slow-down in the rise of public spending was to a large extent due to a reinforced 
policy of budget consolidation which also affected social health insurance that finance at 
least 80% of overall public health expenditure. Effective tools for a deceleration of the 
increase in spending were reduced contracts with physician practices, efficient 
negotiations with pharmaceutical companies, as well as the budgeting of expenditure in 
certain fields of health care.  
The sharp increase in private spending on physician services could be due to people’s 
ever increasing demand for private doctors who practice but who have no contracts 
                                                 
14 Both nominal and overall publich health spending were adjusted by means of the GDP deflator. Private spending, 
however, was adjusted with the help of the price index regarding private consumption of medical services which 
can be found in the OECD Health Data 1998. 
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with social insurance companies. In addition, since 1996 the reimbursement rate for 
patients who see a private physician decreased from 100% to 80% This analysis, 
however, is by no means clear on the question whether the Austrians‘ preference for 
private physicians arises from both a stronger health awareness and higher disposable 
income and /or whether the increased deductible is responsible for the dynamic change 
in health spending. It is highly probable, however, that a mixture of both trends accounts 
for the Austrian status-quo.  
Figure 9: Nominal Health Expenditures per capita, 1981=100
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We are not able to give a detailed enumeration of reasons why private health spending 
rose so excessively, however, the data seem to indicate that the Austrians‘ increased 
care for their health manifested itself in a higher consumption of health care services. 
As already mentioned before, health is probably the population’s supreme asset. 
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Table 3 Nominal average growth rates 
  1981-1997 1982-1989 1990-1997 
Health spending public  6.43 6.32 6.74 
 private  8.03 8.42 7.70 
Private households Co-payments 7.36 8.33 6.35 
 Physician services 9.35 9.17 10.48 
 Private health insurance 6.44 7.11 4.94 
Gross national product  5.42 5.39 4.79 
Total public spending 5.86 5.5 5.65 
Total health spending 6.70 6.67 6.85 
Source: Central Statistical Office, December 1998, calculations by IHS-HealthEcon, 1999. 
5.2 Elasticities of health spending in Austria between 1981 and 1997 
Between 1981 and 1997 the relative increase in nominal health spending per capita 
ranged between 1.24 and 1.37 (95% confidence interval). Within the same period of 
time, private consumption expenditure experienced a proportional rise between 1.48 
and 1.64 while public consumption spending grew between 1.18 and 1.31. (Table 4)15. 
Compared to relative public spending in the periods 1982 to1989 and 1990 to 1997 
respectively, the elasticity of private spending was 24 percent and 11 percent higher. 
This higher elasticity of private households health spending confirms the observations in 
figure 9 and reinforces the evidence indicated in table 4. 
Table 4 Income elasticities for health spending (HS) 1981-1997 a) 
  coefficient confidence belt of 95%  confidence belt of 95% coefficient of  
HS  GDP lower limit upper limit constant 
term 
lower limit upper limit determination 
total 1981-1997 1.30*** 1.24 1.37 -2.76*** -3.09 -2.42 0.99 
 1982-1989b) 1.31*** 1.16 1.46 -2.78*** -3.58 -1.98 0.98 
 1990-1997 b) 1.50*** 1.25 1.74 -3.80*** -5.13 -2.47 0.97 
private 1981-1997 1.56*** 1.48 1.64 -4.72*** -5.15 -4.29 0.99 
 1982-1989 b) 1.57*** 1.25 1.89 -4.78*** -6.44 -3.12 0.95 
 1990-1997 b) 1.65*** 1.45 1.84 -5.20*** -6.27 -4.12 0.98 
public 1981-1997 1.25*** 1.18 1.31 -2.58*** -2.94 -2.23 0.99 
 1982-1989 b) 1.26*** 1.12 1.40 -2.65*** -3.41 -1.90 0.99 
 1990-1997 b) 1.49*** 1.19 1.78 -3.89*** -5.48 -2.29 0.96 
a)  OLS-Regressions according to model 1;  
b)  in order to have symmetric periods to compare, seven year intervals were chosen. 
*** p£0.001 
Source: Central Statistical Office, December 1998, IHS HealthEcon-calculations1999.  
                                                 
15 By using the deflator for Austrian health care expenditure, we see that elasticity ranged between 0.63 and 0.86 
(within a 95% confidence limit) which means that real health spending rose degressively in relation to real GDP per 
capita. With regard to an increase in services performed, a variety of new goods and services, as well as a 
steadily rising life expectancy, these results contradict every experience made so far. In an OECD cross-sectional 
study of 18 countries (1987) elasticity of real health spending amounted to 1.6%. OECD: Financing and delivering 
Health Care (1987), Paris. 
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Figure 11 shows the increase in the Austrian health care system’s prices split up into 
the individual components of the index. The costs for hospital treatment and the fees of 
physicians rose strongest tightly followed by prescription charges and the costs for new 
glasses. It is generally assumed, however, that the rise in the Austrian health care 
system’s prices is overestimated16 since the individual factors of the price index only 
paint a rather selective picture of the real situation. The reason for this overestimation of 
prices is that the deflator reflects a trend in fees rather than market prices. It is 
furthermore assumed that certain measures of deregulation led to an increased 
competition in some fields of the health care system and thus provoked a decrease in 
prices in the 90s. From 1994 this development again stimulated the demand and in 
consequence also the consumption of health care services. It has to be taken into 
account, though, that even if the index is distorted and the fees do not represent market 
prices they may comprise monopoly rents which lead to an increase in prices and thus 
negatively affect welfare. Recent debates on the charges for dental crowns show that 
the recommended price which was finally agreed upon is way beyond an equally 
realistic but less profitable price.  
                                                 
16 According to information disseminated by the Central Statistical Office on June 8, 1998, price trends in health care 
were particularly overestimated from 1981 to 1989. Between 1990 and 1996 the real effect probably dominated the 
price effect. The hypothesis thus is that prices sank and turnover rose within this period because more money 
was spent on health care services.  
Figure 11: Average Price Increase 1990 - 1997 
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6 Conclusion: The health care system will expand 
further 
The increase in the health care system‘s price indices17 beyond the rise in the overall 
economic price indices is usually explained by the fact that the system’s productivity 
generally improves on a slower rate than overall economic productivity. This trend in 
turn is due to the fact that the health care system forms part of the service sector. If the 
service sector improves to a lesser extent than the economy as a whole, relative prices 
will rise over time. Consequently, expenditure will increase since the demand for health 
care services is rather insensitive to price changes – a fact that at least holds true for 
the main fields of health care that constitute more than 60% of overall health care 
spending. It is particularly difficult to ascertain improvements in productivity in the field of 
health care, because it is nearly impossible to measure the “final output“. It is, however, 
rather illogical to assume that productivity has not been improved in our health care 
system’s main branches, for example in acute care. It is far more likely, though hard to 
measureable, that productivity in health care has risen. If the quality of treatment is 
improved, it has only slight effects on the price indices. Therefore, it will be even more 
important in future to study factor flow and factor prices over a period of time, as well as 
to reasonably measure productivity with respect to output, i. e., to ascertain real effects 
of rapid product as well as process innovations in the health care sector. 
                                                 
17 Apart from the general level of prices, real income per capita, the use of technological innovations and the 
percentage of people over 65, the density of physicians was identified as a determinant in a recent study. This 
new factor, however, correlated negatively with the increase in prices. In consequence, we might suppose that 
the density of physicians does not simulate demand, as has been generally assumed so far, but that increased 
supply leads to a decrease in prices charged for medical treatment. Cebula, R. J.: Determinants of the inflation rate 
of the health care CPI in the US, Applied Economic Letters 5 (1998), p. 47-49. 
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Table A1 GROSS NATIONAL PRODUCT PER CAPITA EU-15=100 
 Purchasing power parities expressed in U.S. dollars  
 1990 1991 1992 1993 1994 1995 1996 1997 1998 1990 1991 1992 1993 1994 1995 1996 1997 1998 
Austria 16712 17576 18581 19190 20036 20618 21965 22789 22262 1998 110 111 111 110 109 111 110 109 
Belgium 16668 17538 19011 19699 20577 21107 21986 22902 22452 110 110 113 114 113 111 111 110 110 
Denmark 16557 17497 18096 19169 20419 21479 22669 23874 22679 109 110 108 111 112 113 114 115 111 
Germany 14626 17070 18453 18558 19747 20466 21622 22385 21741 96 107 110 108 109 108 109 108 107 
Finland 16203 15540 14868 15636 16330 17911 18634 19821 19814 107 97 89 91 90 94 94 96 97 
France 17358 18244 19003 18684 19279 19909 20464 21290 20695 114 114 113 108 106 105 103 103 101 
Greece 9187 9829 10680 11047 11700 12222 13143 13805 13608 60 62 64 64 64 64 66 67 67 
Great Britain 15907 15758 16600 16881 17558 17865 19055 20139 19669 105 99 99 98 97 94 96 97 96 
Ireland 11378 12149 13465 14255 15713 17198 18190 18875 20245 75 76 80 83 87 91 92 91 99 
Italy 16257 17198 18099 17717 18682 19460 20236 20914 20069 107 108 108 103 103 102 102 101 98 
Luxemburg 22809 24382 26523 28176 30178 31206 31677 33089 32679 150 153 158 163 166 164 160 160 160 
Netherlands 15926 16517 17424 17854 18838 19852 20481 21450 20964 105 104 104 104 104 105 103 103 103 
Portugal 9372 10167 10889 11431 12042 12457 12963 13672 14095 62 64 65 66 66 66 65 66 69 
Sweden 17011 16898 16908 16824 17543 18727 19419 20150 19528 112 106 101 98 97 99 98 97 96 
Spain 11856 12873 13287 13440 13743 14318 15162 15800 15593 78 81 79 78 76 75 76 76 76 
                   
EU-15§ 15188 15949 16792 17237 18159 18986 19844 20730 20406 100 100 100 100 100 100 100 100 100 
EU-EURO§ 15379 16296 17237 17695 18651 19500 20307 21181 20964 101 102 103 103 103 103 102 102 103 
                   
Switzerland 21223 21770 22829 23498 24173 24992 24608 25088 * 140 136 136 136 133 132 124 121 * 
USA 22224 22605 23600 24551 25764 26711 27821 29195 * 146 142 141 142 142 141 140 141 * 
                   
Estonia n.v. 8819 7283 6750 6697 7057 7407 8251 * * 55 43 39 37 37 37 40 * 
Poland 5089 4718 4828 5000 5242 5565 5866 6271 * 34 30 29 29 29 29 30 30 * 
Slovenia 11878 10896 10333 10500 11087 11704 12308 12776 * 78 68 62 61 61 62 62 62 * 
Czech Republic 10027 8825 8268 8200 8414 8759 9184 9193 * 66 55 49 48 46 46 46 44 * 
Hungary 7471 7224 6375 6200 6400 6558 6789 7088 * 49 45 38 36 35 35 34 34 * 
                   
MOEL-5§ 8616 8096 7417 7330 7568 7929 8311 8716 * 57 51 44 43 42 42 42 42 * 
§ unweighed average. 
Sources: OECD-Health Data 1998, data for central and eastern european countries (MOEL-5): Nationale Statistics, WHO Health for All Database 1999, GDP 1998: Eurostat: 
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table agc01u16 ESVG-Aggregate zu jeweiligen Preisen - in $PPP, IHS-HealthEcon calculations 1999. 
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Table A2 OVERALL HEALTH SPENDING PER CAPITA EU-15=100 
 Purchasing power parities expressed in U.S. dollars  
 1990 1991 1992 1993 1994 1995 1996 1997 1990 1991 1992 1993 1994 1995 1996 1997 
Austria 1204 1272 1409 1529 1594 1641 1748 1793 106 103 105 110 110 109 110 109 
Belgium 1248 1382 1516 1600 1656 1664 1708 1747 110 112 113 115 114 110 108 106 
Denmark 1364 1429 1486 1608 1677 1708 1802 1848 120 115 111 116 116 113 114 112 
Germany 1279 1603 1834 1847 1982 2128 2278 2339 112 129 137 133 137 141 144 142 
Finland 1292 1416 1384 1310 1290 1370 1380 1447 113 114 103 94 89 91 87 88 
France 1539 1656 1783 1834 1874 1971 1983 2103 135 134 133 132 130 131 125 128 
Greece 386 415 476 549 636 703 888 974 34 33 35 39 44 47 56 59 
Great Britain 955 1021 1151 1165 1213 1234 1317 1347 84 82 86 84 84 82 83 82 
Ireland 759 855 982 1047 1124 1204 1276 1324 67 69 73 75 78 80 81 80 
Italy 1321 1449 1540 1515 1562 1503 1584 1589 116 117 115 109 108 100 100 97 
Luxemburg 1495 1575 1743 1891 1956 2077 2139 2340 131 127 130 136 135 138 135 142 
Netherlands 1326 1417 1536 1599 1652 1743 1766 1825 116 114 115 115 114 116 112 111 
Portugal 614 731 806 875 941 1025 1071 1125 54 59 60 63 65 68 68 68 
Sweden 1492 1462 1496 1504 1533 1590 1675 1728 131 118 112 108 106 106 106 105 
Spain 815 900 974 1010 1015 1042 1115 1168 72 73 73 73 70 69 70 71 
                 
EU-15§ 1139 1239 1341 1392 1447 1507 1582 1646 100 100 100 100 100 100 100 100 
EU-EURO§ 1172 1296 1410 1460 1513 1579 1641 1709 103 105 105 105 105 105 104 104 
                 
Switzerland 1760 1937 2115 2197 2288 2403 2499 2547 154 156 158 158 158 159 158 155 
USA 2799 3035 3276 3468 3628 3767 3898 4090 246 245 244 249 251 250 246 248 
                 
Estonia 538 480 482 675 735 749 687+ 798+ 47 39 36 48 51 50 43 48 
Poland 224+ 216 234 229 219 225+ 371 323+ 20 17 17 16 15 15 23 20 
Slovenia 311 311 449 654 743 856+ 976+ 1097+ 27 25 33 47 51 57 62 67 
Czech Republic 538 480 482 675 735 749 904 922+ 47 39 36 48 51 50 57 56 
Hungary 322+ 391 424 406 459 562 602 626+ 28 32 32 29 32 37 38 38 
                 
MOEL-5§ 386+ 376 414 528 578 628+ 713+ 753+ 34 30 31 38 40 42 45 46 
§ unweighed average. Estimates achieved by extrapolation. 
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Sources: OECD-Health Data 1998, WHO Health for All Database 1999, yearbook of the polish statistical office 1997, table 7 (697) p. 505, yearbook of the polish 
statistical office 1997, table 24-15 p. 585, IHS-HealthEcon calculations 1999. 
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Table A3 Public health spending EU-15=100 
 as percentage share in overall health spending  
 1990 1991 1992 1993 1994 1995 1996 1997 1990 1991 1992 1993 1994 1995 1996 1997 
Austria 73.5 73.4 73.3 73.9 74.1 73.3 72.0 72.0 92 92 92 93 94 93 94 94 
Belgium 88.9 88.1 88.9 88.9 87.9 87.8 87.7 87.6 111 111 112 112 112 112 114 115 
Denmark 86.1 86.6 86.7 86.3 86.6 86.1 65.2 65.0 108 109 109 109 110 110 85 85 
Germany 76.2 78.2 78.5 77.6 77.6 78.2 78.3 77.4 95 98 99 98 99 100 102 101 
Finland 80.9 81.1 79.6 76.3 74.8 74.7 78.4 77.0 101 102 100 97 95 95 102 101 
France 74.5 74.7 74.6 74.2 78.4 80.6 80.7 78.4 93 94 94 94 100 103 105 102 
Greece 82.3 80.2 76.1 76.2 76.2 75.8 77.5 74.8 103 101 96 96 97 97 101 98 
Great Britain 84.1 83.7 84.5 84.8 84.1 84.4 84.5 84.5 105 105 107 107 107 108 110 110 
Ireland 72.9 74.4 75.1 75.3 75.2 74.7 74.2 75.0 91 93 95 95 95 95 96 98 
Italy 78.1 78.4 76.3 73.1 70.6 69.3 69.8 69.9 98 98 96 92 90 88 91 91 
Luxemburg 93.1 93.0 92.8 92.9 91.8 92.4 92.6 91.8 117 117 117 118 117 118 120 120 
Netherlands 72.7 74.1 77.4 78.3 77.5 76.7 72.1 72.0 91 93 98 99 98 98 94 94 
Portugal 65.5 62.8 59.6 63.0 63.4 60.5 59.8 60.0 82 79 75 80 80 77 78 78 
Sweden 89.9 88.2 87.2 85.7 84.6 83.4 83.0 83.3 113 111 110 108 107 106 108 109 
Spain 78.7 78.7 78.7 79.1 78.7 78.7 78.7 78.7 99 99 99 100 100 100 102 103 
                 
EU-15§ 79.8 79.7 79.3 79.0 78.8 78.4 77.0 76.5 100 100 100 100 100 100 100 100 
EU-EURO§ 77.7 77.9 77.7 77.5 77.3 77.0 76.8 76.3         
                 
Switzerland 68.4 68.6 70.1 71.8 72.1 72.3 70.0 69.9 86 86 88 91 92 92 91 91 
USA 40.7 41.9 42.9 43.5 44.8 45.9 46.7 46.7 51 53 54 55 57 59 61 61 
                 
Estonia * * * * * * 88.0 87.0 * * * * * * 114 114 
Poland 100.0 94.1 93.6 93.5 93.5 93.1 92.7 93.0 125 118 118 118 119 119 120 122 
Slovenia 100.0 100.0 100.0 93.0 91.0 89.7 89.1 88.3 125 125 126 118 116 114 116 115 
Czech Republic 96.2 96.7 95.4 94.8 93.9 92.6 92.4 92.0 121 121 120 120 119 118 120 120 
Hungary 100.0 100.0 91.9 71.1 71.7 69.8 69.3 69.1 125 125 116 90 91 89 90 90 
§ unweighed average,  
Sources: WHO Health for All Database 1999, OECD-Health Data 1998, calculations by IHS-HealthEcon, 1999. 
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